Fortune Oil's Health-Focused Campaign Strategy

Executive Summary

Fortune, India's largest selling edible oil brand under what was Adani Wilmar Limited (now AWL Agri Business Limited), has pursued health positioning as a sustained strategic imperative across multiple campaign phases — from disease-specific product claims to FSSAI-compliant nutritional communication and CSR-linked social health initiatives. This case examines the evolution of Fortune's health-focused strategy: its commercial logic, its campaign architecture, the regulatory crisis triggered by overreach in health claims, and the recalibrated approach that followed. The case offers a rare opportunity to study how a market-leading FMCG brand navigated the intersection of consumer health insight, regulatory constraint, and brand credibility in a category where functional differentiation is structurally limited.

Industry & Competitive Context

India's branded edible oil market is among the most price-sensitive and commoditised segments in the FMCG sector. The category is structurally defined by low consumer involvement, high price elasticity, and limited intrinsic product differentiation — making brand-building through advertising both strategically critical and operationally complex. The branded segment, which competes with unbranded loose oil sold through local retailers, has historically grown by converting unbranded consumption into organised, packaged formats. As of 2021, the branded edible oil market in India was characterised by Adani Wilmar holding an 18.3% market share — the single largest share in the domestic edible oil industry, as disclosed in the company's public filings. The company was a market leader in soyabean oil, mustard oil, and rice bran oil, and ranked among the top three players in palm oil and sunflower oil. Competitors in the health oil sub-segment included Marico's Saffola (which had pioneered heart-health positioning in edible oils in India through its sustained "heart health" messaging) and Emami Agrotech's Healthy & Tasty brand, among others. The competitive context is important because Saffola's decade-long association with cardiac care had already educated a subset of Indian consumers about health-differentiated oils. Fortune's health campaigns, therefore, entered a market where health positioning was not new but was concentrated in the premium sub-segment and not yet extended to the mass mid-price segment that Fortune predominantly served. Post-pandemic India saw a significant acceleration in health consciousness among Indian consumers. Adani Wilmar's own management commentary, cited in official press materials for the 2023 "Health Aaj Se" campaign, explicitly acknowledged that "Indians have become extremely health-conscious in the post-pandemic world" — making health positioning not merely an aspiration but a response to a documented shift in the consumer's purchase decision framework.

Brand Situation Prior to Health Campaigns

Fortune was launched in 2000, the same year Adani Wilmar commissioned its first oil refinery at Mundra, Gujarat — one of the largest port-based refinery facilities in India with a designed capacity that would grow to 5,000 metric tonnes per day. The brand was built on a mass-market value proposition: delivering refined, packaged, quality cooking oil at an accessible price to a consumer base that was transitioning from unbranded loose oil to organised, branded formats. By the mid-2010s, Fortune had become the top edible oil brand in India by volume, with the company describing its reach as covering approximately one in three Indian households — translating to approximately 113 million households as of December 2022, per Wilmar International's published annual materials. The distribution network comprised more than 10,000 distributors and close to 2.1 million retail outlets. However, market leadership in a commoditised category carries a specific strategic liability: the inability to command a significant price premium without a credible functional differentiator. Health positioning offered Fortune a mechanism to build premium sub-brands above the mass-market price floor, capture a growing segment of health-aware consumers, and insulate portions of the portfolio from pure price competition.

Strategic Objective

Fortune's health-focused campaigns served a layered set of strategic objectives that evolved over time. The first and most immediate objective was premiumisation — creating health-differentiated product lines that could command price points above the base oil category. The second was brand equity reinforcement — associating Fortune not just with price-accessibility but with credible health credentials, a territory that its primary competitor Saffola had effectively occupied at the premium end. The third objective, particularly evident in the post-2020 phase, was to align the brand with India's documented post-pandemic shift toward preventive health consciousness, expanding the addressable market for health-positioned products beyond the premium segment into Fortune's core mid-market constituency. The campaign strategy was not a single initiative but a phased architecture spanning at least three distinct campaign periods: the disease-specific health claim phase (Fortune Vivo, 2016), the cause-led digital health engagement phase (#MakeIndiaDiabetesFree, 2016), and the FSSAI-compliant nutritional communication phase (Fortune Xpert Total Balance Oil, "Health Aaj Se," 2023).

Campaign Architecture & Execution

Phase 1 — Disease-Specific Health Claim: Fortune Vivo (2016)

In February 2016, Adani Wilmar launched Fortune Vivo — positioned as India's first diabetes-care cooking oil. The product was a blend of 80% physically refined rice bran oil and 20% cold-pressed unrefined sesame oil. The brand's campaign made clinical health claims: that the oil was "proven to regulate blood sugar levels," "improves insulin sensitivity," and reduced the need for anti-diabetic medicines. Bollywood actor Parineeti Chopra fronted the campaign. The company's CEO Atul Chaturvedi, in a published interview with Impact Magazine (February 2016), stated that "our research and clinical trials have actually proven that the right blend of Rice Bran oil and Sesame oil can be the answer for at least controlling diabetes if not reducing it." The strategic logic was compelling: India had more than 62 million individuals diagnosed with diabetes at the time, as acknowledged in Fortune's own campaign communications and Business Standard reporting. The company simultaneously launched a digital campaign titled #MakeIndiaDiabetesFree in November 2016, designed to drive awareness about diabetes prevention and position Fortune as a socially committed brand in the health space. COO Angshu Mallick described the campaign in an official press statement as "inspiring individuals to stay ahead of this deadly disease by leading a balanced lifestyle of exercise and eating right."

Phase 2 — Regulatory Crisis and Forced Repositioning

Fortune Vivo's aggressive health claim strategy triggered a multi-front regulatory confrontation. The Advertising Standards Council of India (ASCI) investigated the brand's claims and concluded they were misleading. When Adani Wilmar challenged this ruling in court, the Ahmedabad City Civil Court ruled in January 2017 in favour of ASCI, finding that "Fortune Vivo diabetes care oil with health claim is misleading with ambiguity, and it will affect the health of the general public," as reported by The Ken. Separately, the Government of Maharashtra's Food and Drug Administration conducted a raid on Adani Wilmar's storage facility in Panvel and released an official statement citing violations of FDA regulations related to health claims on product advertising and packaging, as documented in Wikipedia's AWL Agri Business article, citing official government sources. This regulatory sequence is critically important as a case study in the limits of disease-claim marketing for food products. The FSSAI's regulatory framework draws a firm boundary between a food product making a nutritional claim (permissible within defined parameters) and a disease-therapeutic claim (reserved for drugs and pharmaceutical products, not foods). Fortune Vivo's campaign language had crossed this boundary, and the legal and regulatory pushback forced the brand to fundamentally recalibrate its health communication approach.

Phase 3 — FSSAI-Compliant Nutritional Positioning: Fortune Xpert Total Balance Oil (2023)

The third and strategically most mature phase of Fortune's health campaign strategy was the August 2023 launch of Fortune Xpert Total Balance Oil, accompanied by the "Health Aaj Se" campaign conceptualised by Ogilvy. This campaign was architecturally distinct from the Vivo strategy in one critical respect: it grounded all health claims in FSSAI-approved nutritional parameters rather than disease-specific therapeutic claims. The product — a tri-oil blend of soyabean, rice bran, and flaxseed oils — was positioned around its fatty acid balance (SAFA:PUFA:MUFA ratio) and Omega 3:Omega 6 ratio as recommended by FSSAI for a balanced diet based on the average Indian diet. The campaign's creative insight targeted a behaviour that Adani Wilmar described in official press materials as "the highly prevalent tendency of consumers to strategise their health journey 'Kal Se'" — the distinctly Indian phenomenon of perpetually deferring health commitments ("I'll start going to the gym tomorrow," "I'll eat better from next week"). The campaign's answer was: your health journey can begin today, from the kitchen, starting with the oil you cook with — hence, "Health Aaj Se" (Health From Today). Vineeth Viswambharan, Associate Vice President of Marketing and Sales at Adani Wilmar, stated in the official campaign launch communication: "Many of our consumers today have a deep understanding of the varied nutrients present in different oils and they change their edible oils periodically to benefit from the same. We have introduced Fortune Xpert Total Balance which delivers consumers a holistic solution that combines the goodness of three powerful oils. It's a game-changer in the edible oil segment, as Indians have become extremely health-conscious in the post-pandemic world." The Fortune Xpert range also included sub-variants: Fortune Xpert Pro Sugar Conscious and Fortune Xpert Pro Immunity, extending the health portfolio across multiple consumer health concerns while maintaining FSSAI-compliant communication. Additionally, in October 2025, Fortune Sunflower Oil (under the parent now renamed AWL Agri Business) launched a campaign highlighting a "17% less oil absorption" innovation, supported by a regional TVC across Karnataka, Tamil Nadu, Andhra Pradesh, and Telangana, created by Ogilvy. Mukesh Mishra, Joint President of Sales & Marketing at AWL Agri Business, stated in official press materials: "With our new '17% less oil absorption' proposition, we are addressing a vital consumer need for lighter, healthier cooking without compromising on taste."

Positioning & Consumer Insight

Fortune's health campaigns across phases reveal a deepening understanding of the Indian consumer's relationship with dietary health. The initial insight — that Indians were growing more health-conscious and that edible oil represented a daily health touchpoint — was strategically valid but tactically over-executed in the Vivo phase, which conflated a nutritional product with a therapeutic intervention. The more sophisticated consumer insight embedded in the "Health Aaj Se" campaign is worth strategic attention. The campaign identified not just a health aspiration gap ("I want to be healthier") but a behavioural implementation gap ("I keep postponing the actions that would make me healthier"). This is a textbook application of the "Jobs to Be Done" (JTBD) framework: the consumer's job is not simply to "buy healthier oil" but to "feel like they are meaningfully progressing on their health journey without making disruptive lifestyle changes." Switching cooking oil is a low-barrier, kitchen-level health action that creates an immediate sense of health agency — the campaign leveraged this insight to position the product as the accessible starting point of a larger health journey. The "Kal Se" (From Tomorrow) cultural insight is particularly resonant because it reflects a documented human behavioural tendency — the intention-action gap described in behavioural economics — adapted to the specific Indian cultural context where deferred self-care commitments are a widely shared and self-acknowledged behaviour pattern.

Media & Channel Strategy

The "Health Aaj Se" 2023 campaign was described in official press materials as a "360-degree campaign" deployed across digital platforms, offline modern trade outlets, HD television channels, connected TVs (CTVs), and other alternative media. This multi-channel architecture reflects the documented shift in Indian FMCG media strategy: while television remains the reach vehicle for mass communication, connected TV and digital platforms enable precision targeting of health-conscious, urban, and semi-urban audiences who are disproportionately present in the Fortune Xpert target segment. The October 2025 Fortune Sunflower Oil campaign was initially deployed as a regional TVC in southern markets — Karnataka, Tamil Nadu, Andhra Pradesh, and Telangana — before extending to digital platforms. Official press communications from AWL Agri Business confirmed the messaging was also integrated into product packaging design, creating a point-of-purchase layer that reinforces health communication at the moment of purchase decision. The Fortune Xpert range was confirmed to be available on multiple e-commerce platforms, per official brand communications — recognising that health-conscious urban consumers are disproportionately active on online grocery platforms. The #MakeIndiaDiabetesFree campaign (2016) was specifically positioned as a digital campaign, reflecting the brand's use of lower-cost digital media for purpose-driven brand-building as a complement to mainstream advertising. The Fortune Xpert Total Balance Oil received the "Product Launch of the Year Award" at the Channelier FMCG Awards 2022, as listed in the company's official awards catalogue.

Business & Brand Outcomes

The following outcomes are drawn exclusively from verified public sources:

Market Position: As of 2021, Adani Wilmar held an 18.3% market share in the branded edible oil market — the single-largest share in the domestic industry — as disclosed in public company materials. The company was the market leader in soyabean oil, mustard oil, and rice bran oil, and among the top three in palm oil and sunflower oil.

Distribution Scale: The company's distribution network comprised more than 10,000 distributors and close to 2.1 million retail outlets, as confirmed in publicly available company documentation. One out of three Indian households was described as a user of AWL products as of December 2022, in Wilmar International's published annual materials.

Fortune Xpert Recognition: Fortune Xpert Total Balance Oil received the "Product Launch of the Year" award at the Channelier FMCG Awards 2022, as listed in official company award records. Fortune brand was also awarded "Brand of the Year" by Team Marksmen in the same year.

Su Poshan CSR Outcomes (Documented): The Fortune SuPoshan project, launched in May 2016 and executed by Adani Foundation across 239 villages in 10 sites across seven states, documented a significant reduction in malnutrition indicators among children aged 0–5. Per Adani Wilmar's published statement (reported by Devdiscourse, September 2021), severe acute malnourishment rates across project sites declined from 8.62% to 4.1%, moderate acute malnourishment declined from 15.78% to 1.3%, and underweight rates declined from 34.3% to 2.7% over four years of intervention. The project was also recognised with the "CSR Project of the Year" award at the 8th CSR Impact Awards, as listed in official company records. The Fortune SuPoshan initiative won the "Social Impact Award" from CSR Universe in the Health & Sanitation category, per official company award documentation.

Most Trusted Brand: Fortune was awarded the "Most Trusted Brand" recognition by Reader's Digest for six consecutive years, as documented in official Adani Wilmar materials.

Regulatory Outcome on Vivo: The Ahmedabad City Civil Court ruled against Fortune Vivo's diabetes-care health claim in January 2017, as reported by The Ken and corroborated by Wikipedia's AWL Agri Business article. The Maharashtra FDA also conducted a warehouse raid and issued an official violation notice regarding Fortune Vivo's advertising claims in 2016, per officially documented government statements.

Strategic Implications

The Regulatory Red Line in Health Claim Marketing

Fortune Vivo's regulatory crisis is the most instructive episode in this case for marketing practitioners and strategists. The FSSAI framework distinguishes categorically between a food product making a "nutritional claim" (e.g., "high in Omega 3," "good source of PUFA," "balanced fatty acid profile") and a "health claim" that implies disease prevention or therapeutic benefit. Fortune Vivo's campaign crossed from the first into the second, and the legal and regulatory response was swift and public. The strategic lesson is that disease-claim marketing for food products requires not just clinical evidence but regulatory pre-clearance — a bar that Indian FMCG companies have consistently underestimated.

The subsequent architecture of Fortune Xpert's "Health Aaj Se" campaign demonstrates a company that internalised this lesson: every health claim was anchored in FSSAI-recommended nutritional ratios, not disease management language. This shift represents the difference between regulatory compliance as a constraint and regulatory compliance as a creative brief.

Health Positioning as a Premiumisation Vector

Fortune's health strategy is fundamentally a premiumisation play within a commoditised category. By creating distinct product sub-lines (Fortune Vivo, Fortune Xpert Total Balance, Fortune Xpert Pro Sugar Conscious, Fortune Xpert Pro Immunity, Fortune Rice Bran Health Oil) with health-differentiated positioning, the company built a tiered portfolio that allows consumers to self-select into higher price bands based on specific health concerns — diabetes, immunity, cholesterol, and general nutritional balance. This mirrors the tiered portfolio logic seen in other FMCG categories (e.g., skincare, personal care) where a mass-market anchor brand coexists with a premium health-differentiated sub-brand architecture.

The strategic risk is brand coherence: if too many health sub-brands proliferate under the Fortune umbrella, the parent brand's identity may become diffuse, reducing the mental availability advantage that scale affords. Managing this architecture requires clear consumer segmentation and distinct, non-overlapping positioning for each sub-brand.

The Behavioural Insight Advantage of "Health Aaj Se"

The creative insight underlying "Health Aaj Se" is strategically superior to its predecessor campaigns because it works with documented consumer behaviour rather than against it. Vivo's campaign asked consumers to believe a bold new product claim (diabetes-care oil), which required trust-building in an unfamiliar category. "Health Aaj Se" instead identifies a behaviour the consumer already self-recognises and self-mocks — the "Kal Se" deferral syndrome — and positions the product as a frictionless first step toward a health journey the consumer already wants to begin. This lowers the psychological barrier to purchase by reframing the product not as a sacrifice or a medical intervention but as an easy starting point.

CSR as Brand Equity Builder: The SuPoshan Model

The Fortune SuPoshan initiative demonstrates a sophisticated understanding of how cause-led brand-building can reinforce health positioning with genuine social credibility. By addressing malnutrition and anaemia in children — a problem structurally linked to nutrition, which is the core brand territory of an edible oil company — Fortune created a CSR programme whose thematic alignment with the brand's commercial positioning is organic, not forced. The documented outcomes (reductions in malnutrition across 239 villages) provided measurable, independently verifiable social impact that amplified brand trust credentials in a way that paid advertising cannot replicate. The recognition of this initiative through multiple public awards further validated the programme's credibility.

The First-Mover Dilemma in Category Creation

Fortune's introduction of Fortune Vivo as "India's first diabetes-care cooking oil" illustrates a recurring tension in new category creation: being first means bearing the cost of consumer education and regulatory ambiguity, but also absorbing reputational damage if the category definition proves legally untenable. Fortune paid the first-mover penalty in the therapeutic oil category. The Xpert range's subsequent positioning — staying within the nutritional claim boundary rather than attempting disease management claims — suggests the company concluded that category creation through compliant nutritional differentiation is more durable than through disease-claim innovation.

Conclusion

Fortune Oil's health-focused campaign strategy offers a multi-phase case study in how India's largest edible oil brand has attempted to build health equity in a commoditised category — with significant success in market share and brand trust, one notable regulatory failure, and an evolving campaign architecture that reflects institutional learning. The journey from Fortune Vivo's disease-claim overreach to Fortune Xpert's FSSAI-anchored nutritional communication represents a meaningful strategic recalibration. The "Health Aaj Se" campaign's behavioural insight — addressing the consumer's own self-acknowledged health-deferral tendency — marks a maturation in the brand's consumer understanding. As the edible oil category continues to premiumise and Indian consumers' health sophistication deepens, Fortune's ability to maintain trust, comply with tightening regulatory standards, and build emotionally resonant health narratives will determine whether it consolidates or loses its market leadership position.

Discussion Questions

1. Regulatory Strategy and Health Claim Design: Fortune Vivo's campaign made disease-management claims that were subsequently found misleading by ASCI and a civil court. Using the FSSAI regulatory framework as a reference, evaluate how Fortune should have structured its health communication strategy for Vivo at launch. What are the strategic implications for FMCG companies navigating the boundary between "nutritional claims" and "health/disease claims" in India?

   
   

2. Portfolio Architecture and Brand Coherence: Fortune operates a portfolio of health-differentiated sub-brands — Vivo, Xpert Total Balance, Xpert Pro Sugar Conscious, Xpert Pro Immunity, Rice Bran Health Oil — alongside its mass-market product lines. Using Aaker's Brand Portfolio Strategy or Keller's Brand Hierarchy framework, evaluate the risks and benefits of this architecture. At what point does health sub-brand proliferation dilute the parent brand's mental availability advantage?

   
   

3. Behavioural Insight as Campaign Strategy: The "Health Aaj Se" campaign's core insight targets the "Kal Se" deferral behaviour — a culturally resonant, self-acknowledged behaviour pattern. Compare this insight-led approach with the disease-claim approach of Fortune Vivo. Which approach is more likely to build durable brand equity, and why? What role does behavioural economics play in designing effective FMCG health campaigns?

   
   

4. CSR as Brand Equity Investment: The Fortune SuPoshan initiative documented measurable reductions in child malnutrition across 239 villages. Evaluate the strategic alignment between this CSR programme and Fortune's commercial brand positioning. Under what conditions does a cause-led CSR programme generate genuine brand equity, and when does it risk being perceived as cause-washing?

   
   

5. Competitive Positioning Against Saffola: Marico's Saffola has held a sustained "heart health" positioning in India's edible oil market for decades, primarily in the premium segment. Fortune's health campaigns target a broader, more price-accessible market. Evaluate the competitive implications of this positioning strategy. Should Fortune attempt to directly challenge Saffola's premium health equity, or is it strategically more valuable to own the "mass-market health" positioning space? What are the risks of each approach?